A novel germ-line mutation in the noncoding region of the p53 gene in a Li-Fraumeni family

Cancer Genetics and Cytogenetics

Volumn 103, Issue 1, 1998, Pages 1-6

  Barel, Dalit ^a   Avigad, Smadar ^a,b   Mor, Celia ^a,c   Fogel, Mina ^d   Cohen, Ian J ^b   Zaizov, Rina ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^c RABIN MEDICAL CENTER   (Israel)

^d KAPLAN MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PROTEIN P53;

ADOLESCENT; ADULT; ARTICLE; BREAST CARCINOMA; CANCER FAMILY; CASE REPORT; CHILD; CHILDHOOD CANCER; FAMILIAL CANCER; FEMALE; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; MALE; MEDULLOBLASTOMA; NUCLEOTIDE SEQUENCE; PEDIGREE ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RHABDOMYOSARCOMA; TUMOR SUPPRESSOR GENE;

ADOLESCENT; ADULT; CHILD, PRESCHOOL; DNA MUTATIONAL ANALYSIS; FEMALE; GENE EXPRESSION REGULATION; GENES, P53; GERM-LINE MUTATION; HUMANS; LI-FRAUMENI SYNDROME; LOSS OF HETEROZYGOSITY; MALE; PEDIGREE; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032077330     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(97)00258-6     Document Type: Article

References (31)

1. Li FP, Fraumeni JF Jr, Mulvihill JJ, Blattner WA, Dreyfus MG, Tucker MA, Miller RW (1988): A cancer family syndrome in twenty-four kinders. Cancer Res 48:5358-5362.
2. Hollstein M, Sidransky D, Vogelstein B, Harris CC (1991): p53 mutations in human cancers. Science (Wash DC) 253: 49-53.
3. Greenblatt MS, Bennett WP, Hollstein M, Harris CC (1994): Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis. Cancer Res 54:4855-4878.
4. Malkin D, Li FP, Strong LC, Fraumeni JF, Nelson CE, Kim DH, Kassel J, Gryka MA, Bischoff FZ, Tainsky MA, Friend SH (1990): Germline p53 mutations in a familial syndrome of breast cancer, sarcomas and other neoplasms. Science 250: 1233-1238.
5. Malkin D (1993): p53 and the Li-Fraumeni syndrome (review). Cancer Genet Cytogenet 66:83-92.
6. Malkin D (1994): p53 and the Li-Fraumeni syndrome. Biochem Biophys Acta 1198:197-213.
7. de Fromental CC, Soussi T (1992): TP53 tumor suppressor gene: A model for investigating human mutagenesis. Genes Chromosom Cancer 4:1-15.
8. Foti A, Bareli M, Ahuja HG, Cline MJ (1990): A splicing mutation accounts for the lack of p53 gene expression in a CML blast crisis cell line: A novel mechanism of p53 gene in activation. Br J Haematol 76:143-145.
9. Sameshima Y, Akiyama T, Mori N, Mizoguchi H, Toyoshima K, Sugimura T, Terada M, Yokota J (1990): Point mutation of the p53 gene resulting in splicing inhibition in small cell lung carcinoma. Biochem Biophys Res Commun 173:697-703.
10. Takahashi T, D'Amico D, Chiba I, Buchhagen DL, Minna JD (1990): Identification of intronic point mutations as an alternative mechanism for p53 in activation in lung cancer. J Clin Invest 86:363-369.
11. Warneford SG, Witton LJ, Townsend ML, Rowe PB, Reddel RR, Dalla-Pozza L, Symonds G (1992): Germ-line splicing mutations of the p53 gene in a cancer-prone family. Cell Growth Differ 3:839-846.
12. Felix CA, Strauss EA, D'Amico D, Tsokos M, Winter S, Mitsudomi T, Nau MM, Brown DL, Leahey AM, Horowitz ME, Poplack DG, Costin D, Minna JD (1993): A novel germline p53 splicing mutation in a pediatric patient with a second malignant neoplasm. Oncogene 8:1203-1210.
13. Jolly KW, Malkin D, Douglass EC, Brown TF, Sinclair AE, Look AT (1994): Splice-site mutation of the p53 gene in a family with hereditary breast-ovarian cancer. Oncogene 9: 97-102.
14. Jego N, Thomas G, Hamelin R (1993): Short direct repeats flanking deletions, and duplicating insertions in p53 gene in human cancers. Oncogene 8:209-213.
15. Strauss EA, Hosler MR, Herzog P, Salhany K, Louie R, Felix CA (1995): Complex replication error causes p53 mutation in a Li-Fraumeni family. Cancer Res 55:3237-3241.
16. Miller SA, Dykes DD, Polesky HF (1988): A simple salting: Our procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 3:1215.
17. Hahn M, Serth J, Fislage R, Wolfes H, Allhoff E, Jones U, Pingoud A (1993): Polymerase chain reaction detection of a highly polymorphic VNTR segment in intron 1 of the human p53 gene (letter). Clin Chem 39:549-550.
18. Greenwald BD, Harpaz N, Yin J, Huang Y, Tong Y, Brown VL, McDaniel T, Newkirk C, Resau JH, Meltzer SJ (1992): Loss of heterozygosity affecting the p53, Rb and mcc/apc tumor suppressor gene loci in dysplastic and cancerous ulcerative colitis. Cancer Res 52:741-745.
19. McDaniel T, Carbone D, Takahashi T, Chumakov P, Chang EH, Pirollo KF, Yin J, Huang Y, Meltzer SJ (1991): The MspI polymorphism in intron 6 of p53 (TP53) detected by digestion of PCR products. Nucleic Acids Res 19:4796.
20. Orita M, Iwahana H, Kanazawa H, Hayashi K, Sekiya T (1989): Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci USA 86:2766-2770.
21. White MB, Carralho M, Derse D, O'Brien SJ, Dean M (1992): Detecting single base substitutions as heteroduplex polymorphism. Genomics 12:301-306.
22. Barel D, Avigad S, Michovitz S, Cohen IJ, Zaizov R (1997): Infrequent p53 mutation and mdm-2 gene amplification in childhood brain tumors. Int J Pediatr Hematol Oncol 4:91-100.
23. Sanger F, Nickln S, Coulson AR (1977): DNA sequencing with chain determinating inhibitors. Proc Natl Acad Sci USA 47:5463-5467.
24. Premoli-De-Percoco G, Guevara P, Galindo I, Ramirez JL (1994): Rapid recovery of DNA from paraffin embedded tissue sections for routine polymerase chain reaction analysis. Methods Mol Cell Biol 4:266-268.
25. Fogel M, Lifschitz-Mercer B, Moll R, Kushnir I, Jacob N, Waldherr R, Livoff A, Franke WW, Czernobilsky B (1990): Heterogeneity of intermediate filament expression in human testicular seminomas. Differentiation 45:242-249.
26. Krontiris TG, DiMartino NA, Colb M, Parkinson DR (1985): Unique allelic restriction fragments of the human Ha-ras locus in leukocyte and tumor DNAs of cancer patients. Nature 313:369-374.
27. Green M, Krontiris TG (1993): Allelic variation of reporter gene activation by the HRAS1 minisatellite. Genomics 17:429-434.
28. Peller S, Kopilova Y, Slutzki S, Halevy A, Kvitko K, Rotter V (1995): A novel polymorphism in intron 6 of the human p53 gene: A possible association with cancer predisposition and susceptibility. DNA Cell Biol 14:980-990.
29. Avigad S, Barel D, Blau O, Malka A, Zoldan M, Mor C, Cohen IJ, Stark B, Goshen Y, Stein J, Zaizov R (1997): A novel germline p53 mutation in intron 6 in diverse childhood malignancies. Oncogene 14:1541-1545.
30. Birch JM, Heighway J, Teare MD, Kelsey AM, Hartley AL, Tricker KJ, Crowther D, Lane DP, Santibanez-Koref MF (1994): Linkage studies in a Li-Fraumeni family with increased expression of p53 protein but no germline mutation in p53. Br J Cancer 70:1176-1181.
31. Barnes DM, Hanby AM, Gillett CE, Mohammed S, Hodgson S, Bobrow LG, Leigh IM, Purkis T, Macgeoch C, Spurr NK, Bartek J, Vojtesek B, Picksley SM, Lane DP (1992): Abnormal expression of wild type p53 protein in normal cells of a cancer family patient. Lancet 340:259-263.